Literature DB >> 2748339

The isopropoxyacetic group for convenient base protection during solid-support synthesis of oligodeoxyribonucleotides and their triester analogs.

B Uznanski1, A Grajkowski, A Wilk.   

Abstract

Isopropoxyacetic anhydride was successfully used for protection of exoaminofunctions of 2'-deoxyadenosine, -guanosine and -cytidine. N-isopropoxyacetylated nucleosides are stable under the conditions of the synthesis of oligodeoxyribonucleotides on the solid support. Removal of N-isopropoxyacetyl is much faster than that of commonly used benzoyl or isobutyryl groups viz. it is completed within the operation of cleavage of the oligodeoxyribonucleotide from the solid support. This observation enabled synthesis of -OCH2CH3 and -OCH2CF3 triesters, which hydrolyse partially or completely when standard deprotection conditions are applied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748339      PMCID: PMC318037          DOI: 10.1093/nar/17.12.4863

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  3 in total

1.  Letter: Phosphite coupling procedure for generating internucleotide links.

Authors:  R I Letsinger; J L Finnan; G A Heavner; N B Lunsford
Journal:  J Am Chem Soc       Date:  1975-05-28       Impact factor: 15.419

2.  Alkyl phosphotriester modified oligodeoxyribonucleotides. V. Synthesis and absolute configuration of Rp and Sp diastereomers of an ethyl phosphotriester (Et) modified EcoRI recognition sequence, d[GGAA(Et)TTCC]. A synthetic approach to regio- and stereospecific ethylation-interference studies.

Authors:  K A Gallo; K L Shao; L R Phillips; J B Regan; M Koziolkiewicz; B Uznanski; W J Stec; G Zon
Journal:  Nucleic Acids Res       Date:  1986-09-25       Impact factor: 16.971

3.  The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups.

Authors:  J C Schulhof; D Molko; R Teoule
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

  3 in total
  7 in total

1.  Advanced method for oligonucleotide deprotection.

Authors:  S A Surzhikov; E N Timofeev; B K Chernov; J B Golova; A D Mirzabekov
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Expression and characterization of the multiplied, recombinant preS1 antigen of hepatitis B virus.

Authors:  M Sidorkiewicz; G Płucienniczak; A Płucienniczak
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Cleavage of oligodeoxyribonucleotides from controlled-pore glass supports and their rapid deprotection by gaseous amines.

Authors:  J H Boal; A Wilk; N Harindranath; E E Max; T Kempe; S L Beaucage
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

4.  Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.

Authors:  Thulani H Senanayake; Galya Warren; Xin Wei; Serguei V Vinogradov
Journal:  J Control Release       Date:  2013-02-04       Impact factor: 9.776

5.  Significance of stereochemistry of 3'-terminal phosphorothioate-modified primer in DNA polymerase-mediated chain extension.

Authors:  Barbara Nawrot; Natasha Paul; Beata Rebowska; Wojciech J Stec
Journal:  Mol Biotechnol       Date:  2008-09-04       Impact factor: 2.695

6.  On the rapid deprotection of synthetic oligonucleotides and analogs.

Authors:  N N Polushin; A M Morocho; B C Chen; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

7.  Antisense pro-drugs: 5'-ester oligodeoxynucleotides.

Authors:  N N Polushin; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.